Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer.

Iiizumi M, Bandyopadhyay S, Pai SK, Watabe M, Hirota S, Hosobe S, Tsukada T, Miura K, Saito K, Furuta E, Liu W, Xing F, Okuda H, Kobayashi A, Watabe K.

Cancer Res. 2008 Sep 15;68(18):7613-20. doi: 10.1158/0008-5472.CAN-07-6700.

2.

Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.

Furuta E, Pai SK, Zhan R, Bandyopadhyay S, Watabe M, Mo YY, Hirota S, Hosobe S, Tsukada T, Miura K, Kamada S, Saito K, Iiizumi M, Liu W, Ericsson J, Watabe K.

Cancer Res. 2008 Feb 15;68(4):1003-11. doi: 10.1158/0008-5472.CAN-07-2489.

3.

The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.

Bandyopadhyay S, Wang Y, Zhan R, Pai SK, Watabe M, Iiizumi M, Furuta E, Mohinta S, Liu W, Hirota S, Hosobe S, Tsukada T, Miura K, Takano Y, Saito K, Commes T, Piquemal D, Hai T, Watabe K.

Cancer Res. 2006 Dec 15;66(24):11983-90.

4.

Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression.

Bandyopadhyay S, Zhan R, Chaudhuri A, Watabe M, Pai SK, Hirota S, Hosobe S, Tsukada T, Miura K, Takano Y, Saito K, Pauza ME, Hayashi S, Wang Y, Mohinta S, Mashimo T, Iiizumi M, Furuta E, Watabe K.

Nat Med. 2006 Aug;12(8):933-8. Epub 2006 Jul 23.

PMID:
16862154
5.

Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells.

Bandyopadhyay S, Zhan R, Wang Y, Pai SK, Hirota S, Hosobe S, Takano Y, Saito K, Furuta E, Iiizumi M, Mohinta S, Watabe M, Chalfant C, Watabe K.

Cancer Res. 2006 Jun 1;66(11):5934-40.

6.

FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis.

Bandyopadhyay S, Pai SK, Watabe M, Gross SC, Hirota S, Hosobe S, Tsukada T, Miura K, Saito K, Markwell SJ, Wang Y, Huggenvik J, Pauza ME, Iiizumi M, Watabe K.

Oncogene. 2005 Aug 11;24(34):5389-95.

PMID:
15897909
7.

PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.

Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Tsukada T, Miura K, Takano Y, Saito K, Commes T, Piquemal D, Watabe M, Gross S, Wang Y, Huggenvik J, Watabe K.

Cancer Res. 2004 Nov 1;64(21):7655-60.

8.

Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression.

Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Takano Y, Saito K, Piquemal D, Commes T, Watabe M, Gross SC, Wang Y, Ran S, Watabe K.

Oncogene. 2004 Jul 22;23(33):5675-81.

PMID:
15184886
9.

The Drg-1 gene suppresses tumor metastasis in prostate cancer.

Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M, Watabe K.

Cancer Res. 2003 Apr 15;63(8):1731-6.

10.

Identification of tumor metastasis suppressor region on the short arm of human chromosome 20.

Goodarzi G, Mashimo T, Watabe M, Cuthbert AP, Newbold RF, Pai SK, Hirota S, Hosobe S, Miura K, Bandyopadhyay S, Gross SC, Balaji KC, Watabe K.

Genes Chromosomes Cancer. 2001 Sep;32(1):33-42.

PMID:
11477659
11.

Localization of a novel tumor metastasis suppressor region on the short arm of human chromosome 2.

Mashimo T, Goodarzi G, Watabe M, Cuthbert AP, Newbold RF, Pai SK, Hirota S, Hosobe S, Miura K, Bandyopadhyay S, Gross SC, Watabe K.

Genes Chromosomes Cancer. 2000 Jul;28(3):285-93.

PMID:
10862034
12.

p53 mutations in tumor and non-tumor tissues of thorotrast recipients: a model for cellular selection during radiation carcinogenesis in the liver.

Iwamoto KS, Fujii S, Kurata A, Suzuki M, Hayashi T, Ohtsuki Y, Okada Y, Narita M, Takahashi M, Hosobe S, Doishita K, Manabe T, Hata S, Murakami I, Hata S, Itoyama S, Akatsuka S, Ohara N, Iwasaki K, Akabane H, Fujihara M, Seyama T, Mori T.

Carcinogenesis. 1999 Jul;20(7):1283-91.

PMID:
10383902
13.

The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53.

Mashimo T, Watabe M, Hirota S, Hosobe S, Miura K, Tegtmeyer PJ, Rinker-Shaeffer CW, Watabe K.

Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11307-11.

14.

Possibility of defense against colorectal tumor by foamy cells.

Hirota S, Hosobe S, Ikeda M, Himori M, Miyashita M, Takemoto Y, Asakura H.

J Clin Gastroenterol. 1997 Mar;24(2):82-6.

PMID:
9077722
15.

Ki-67 and p53 immunoreactive stain and early colorectal neoplasms.

Hirota S, Hosobe S, Ikeda M, Kobayashi T, Himori M, Takemoto Y, Asakura H.

J Exp Ther Oncol. 1996 Sep;1(5):317-21.

PMID:
9414420
16.

p53 immunoreactive stain and early colorectal adenocarcinomas.

Hirota S, Kudo S, Hosobe S, Kobayashi T, Himori M, Ikeda M, Takemoto Y, Nomoto M, Aoyagi Y, Asakura H.

Eur J Cancer. 1995 Dec;31A(13-14):2220-2.

PMID:
8652246
17.

Colorectal tumours and pit pattern.

Kudo S, Hirota S, Nakajima T, Hosobe S, Kusaka H, Kobayashi T, Himori M, Yagyuu A.

J Clin Pathol. 1994 Oct;47(10):880-5.

18.

[Endometriosis of the uterine wall and spontaneous rupture of the pregnant uterus].

KAWABARA H, YAZAKI H, HOSOBE S.

Jpn J Med Sci Biol. 1962 Aug 1;48:177-80. Japanese. No abstract available.

PMID:
14454524

Supplemental Content

Loading ...
Support Center